Company Name Spero Therapeutics
Mailing Address 400 Technology Square 10th Floor Cambridge, MA 20139 USA
Company Description Spero Therapeutics’ vision is to find, develop, and advance groundbreaking therapeutics to meet critical patient needs in infectious disease using a unique business and drug discovery model. Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections.
Proceeds Purposes All six of the previous investors in Spero Therapeutics joined in the Series B round announced today, which will help the startup work toward human trials of what it calls its Potentiator Platform, intended to make existing anti-infective medications more effective in fighting bacteria.